INDEPENDENCE, Va., Nov. 19 /PRNewswire/ -- Harvest Pharmaceuticals Inc has reintroduced Ergomar(R) Sublingual Tablets, 2 mg (ergotamine tartrate tablets, USP) to the marketplace after a manufacturing site change.
Ergomar(R) is indicated as therapy to abort or prevent migraine attacks.
Ergomar(R) Sublingual Tablets contain 2 mg of ergotamine tartrate and are supplied in individual foil strips packaged in a plastic, child resistant canister containing 20 tablets (5- 2 x 2 foil strips).
Harvest Pharmaceuticals Inc is a privately held corporation headquartered in Radford, Virginia. For further information, please telephone 888-374-6627.
Harvest Pharmaceuticals Inc
CONTACT: Steve Kirk of Harvest Pharmaceuticals Inc, +1-888-374-6627